Carmustine
Top View
- New Zealand Data Sheet 1. Product Name 2. Qualitative
- Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
- Threshold of Toxicological Concern (TTC) for Anticancer Compounds
- DRUG NAME: Lomustine
- Carmustine Replacement in Intensive Chemotherapy Preceding Reinjection of Autologous Hscs in Hodgkin and Non-Hodgkin Lymphoma: a Review
- 208630Orig1s000
- Local Alkylating Chemotherapy Applied Immediately After 5-ALA Guided Resection of Glioblastoma Does Not Provide Additional Benefit
- Emetogenic Potential of Antineoplastic Agents
- Current Treatments for Brain Tumors
- Handling Cytostatic Drugs: Contents
- Rapid Regression of Glioblastoma Following Carmustine Wafer Implantation: a Case Report
- Association of High-Dose Cyclophosphamide, Cisplatin, And
- Carmustine and Methotrexate in Combination After Whole Brain
- Carmustine Obvius
- A Randomized Trial of Amifostine and Carmustine-Containing Chemotherapy to Assess Lung-Protective Effects
- Public Assessment Report
- Pharmacist Involvement in the Management of Adverse Effects
- Carmustine Obvius 100 Mg Powder and Solvent for Concentrate for Solution for Infusion